Divis Laboratories Ltd reported 10.68B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Alaunos Therapeutics 0 18K Sep/2024
Aurobindo Pharma INR 29.41B 4.87B Jun/2025
Avita Medical AUD 2.28M 170K Dec/2024
Divis Laboratories Ltd 10.68B 870M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
IQVIA Holdings USD 2.97B 439M Jun/2025
Lupin INR 20.71B 3.85B Jun/2025
Moderna USD 119M 29M Jun/2025
Organon & Co USD 720M 48M Jun/2025
Revvity USD 327.73M 38.51M Jun/2025
Tilray USD 149.73M 9.39M Nov/2024
Viatris USD 2.25B 229.7M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025